>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Partner Fund Management, L.P. Buys Universal Health Services Inc, Eli Lilly and Co, McKesson Corp, Sells Immunomedics Inc, Square Inc, Biomarin Pharmaceutical Inc

San Francisco, CA, based Investment company Partner Fund Management, L.P. (Current Portfolio) buys Universal Health Services Inc, Eli Lilly and Co, McKesson Corp, AbbVie Inc, ACADIA Pharmaceuticals Inc, sells Immunomedics Inc, Square Inc, Biomarin Pharmaceutical Inc, Microsoft Corp, PerkinElmer Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Partner Fund Management, L.P.. As of 2020Q4, Partner Fund Management, L.P. owns 77 stocks with a total value of $2.7 billion. These are the details of the buys and sells.

For the details of Partner Fund Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/partner+fund+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of Partner Fund Management, L.P.
  1. Alexion Pharmaceuticals Inc (ALXN) - 981,131 shares, 5.71% of the total portfolio. Shares added by 39.40%
  2. Outset Medical Inc (OM) - 2,911,207 shares, 5.61% of the total portfolio. Shares added by 1.33%
  3. AbbVie Inc (ABBV) - 926,823 shares, 3.70% of the total portfolio. Shares added by 84.72%
  4. Horizon Therapeutics PLC (HZNP) - 1,328,803 shares, 3.62% of the total portfolio. Shares reduced by 2.25%
  5. Arcus Biosciences Inc (RCUS) - 3,373,460 shares, 3.26% of the total portfolio. Shares added by 32.97%
New Purchase: Universal Health Services Inc (UHS)

Partner Fund Management, L.P. initiated holding in Universal Health Services Inc. The purchase prices were between $105.45 and $139.73, with an estimated average price of $124.71. The stock is now traded at around $129.670000. The impact to a portfolio due to this purchase was 2.26%. The holding were 442,044 shares as of 2020-12-31.

New Purchase: Eli Lilly and Co (LLY)

Partner Fund Management, L.P. initiated holding in Eli Lilly and Co. The purchase prices were between $130.46 and $172.63, with an estimated average price of $149.39. The stock is now traded at around $200.920000. The impact to a portfolio due to this purchase was 2.21%. The holding were 350,645 shares as of 2020-12-31.

New Purchase: McKesson Corp (MCK)

Partner Fund Management, L.P. initiated holding in McKesson Corp. The purchase prices were between $143.79 and $183.66, with an estimated average price of $166.85. The stock is now traded at around $177.620000. The impact to a portfolio due to this purchase was 2%. The holding were 308,987 shares as of 2020-12-31.

New Purchase: UnitedHealth Group Inc (UNH)

Partner Fund Management, L.P. initiated holding in UnitedHealth Group Inc. The purchase prices were between $303.68 and $356.82, with an estimated average price of $335.55. The stock is now traded at around $324.580000. The impact to a portfolio due to this purchase was 1.33%. The holding were 102,099 shares as of 2020-12-31.

New Purchase: Guardant Health Inc (GH)

Partner Fund Management, L.P. initiated holding in Guardant Health Inc. The purchase prices were between $99.96 and $135.93, with an estimated average price of $115.17. The stock is now traded at around $170.450000. The impact to a portfolio due to this purchase was 1.09%. The holding were 227,876 shares as of 2020-12-31.

New Purchase: Bristol-Myers Squibb Company (BMY)

Partner Fund Management, L.P. initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $57.74 and $65.43, with an estimated average price of $61.52. The stock is now traded at around $60.600000. The impact to a portfolio due to this purchase was 1.04%. The holding were 451,275 shares as of 2020-12-31.

Added: AbbVie Inc (ABBV)

Partner Fund Management, L.P. added to a holding in AbbVie Inc by 84.72%. The purchase prices were between $80.49 and $108.67, with an estimated average price of $96.24. The stock is now traded at around $105.010000. The impact to a portfolio due to this purchase was 1.7%. The holding were 926,823 shares as of 2020-12-31.

Added: ACADIA Pharmaceuticals Inc (ACAD)

Partner Fund Management, L.P. added to a holding in ACADIA Pharmaceuticals Inc by 199.10%. The purchase prices were between $41.04 and $56.79, with an estimated average price of $49.76. The stock is now traded at around $51.730000. The impact to a portfolio due to this purchase was 1.67%. The holding were 1,259,474 shares as of 2020-12-31.

Added: Alexion Pharmaceuticals Inc (ALXN)

Partner Fund Management, L.P. added to a holding in Alexion Pharmaceuticals Inc by 39.40%. The purchase prices were between $111.55 and $158.03, with an estimated average price of $128.71. The stock is now traded at around $155.510000. The impact to a portfolio due to this purchase was 1.61%. The holding were 981,131 shares as of 2020-12-31.

Added: AstraZeneca PLC (AZN)

Partner Fund Management, L.P. added to a holding in AstraZeneca PLC by 182.19%. The purchase prices were between $48.52 and $58.02, with an estimated average price of $52.94. The stock is now traded at around $50.590000. The impact to a portfolio due to this purchase was 1.32%. The holding were 1,094,600 shares as of 2020-12-31.

Added: Avantor Inc (AVTR)

Partner Fund Management, L.P. added to a holding in Avantor Inc by 63.32%. The purchase prices were between $22.9 and $28.15, with an estimated average price of $25.82. The stock is now traded at around $28.690000. The impact to a portfolio due to this purchase was 0.85%. The holding were 2,074,259 shares as of 2020-12-31.

Added: Arcus Biosciences Inc (RCUS)

Partner Fund Management, L.P. added to a holding in Arcus Biosciences Inc by 32.97%. The purchase prices were between $17 and $32.36, with an estimated average price of $24.32. The stock is now traded at around $31.660000. The impact to a portfolio due to this purchase was 0.81%. The holding were 3,373,460 shares as of 2020-12-31.

Sold Out: Immunomedics Inc (IMMU)

Partner Fund Management, L.P. sold out a holding in Immunomedics Inc. The sale prices were between $85.08 and $87.86, with an estimated average price of $86.65.

Sold Out: Square Inc (SQ)

Partner Fund Management, L.P. sold out a holding in Square Inc. The sale prices were between $154.88 and $241.58, with an estimated average price of $195.49.

Sold Out: Microsoft Corp (MSFT)

Partner Fund Management, L.P. sold out a holding in Microsoft Corp. The sale prices were between $202.33 and $224.96, with an estimated average price of $215.07.

Sold Out: PerkinElmer Inc (PKI)

Partner Fund Management, L.P. sold out a holding in PerkinElmer Inc. The sale prices were between $122.05 and $147.91, with an estimated average price of $133.22.

Sold Out: Hologic Inc (HOLX)

Partner Fund Management, L.P. sold out a holding in Hologic Inc. The sale prices were between $65.85 and $76.67, with an estimated average price of $70.66.

Sold Out: NXP Semiconductors NV (NXPI)

Partner Fund Management, L.P. sold out a holding in NXP Semiconductors NV. The sale prices were between $127.39 and $166.37, with an estimated average price of $147.64.



Here is the complete portfolio of Partner Fund Management, L.P.. Also check out:

1. Partner Fund Management, L.P.'s Undervalued Stocks
2. Partner Fund Management, L.P.'s Top Growth Companies, and
3. Partner Fund Management, L.P.'s High Yield stocks
4. Stocks that Partner Fund Management, L.P. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)